Institution
Drexel University
Education•Philadelphia, Pennsylvania, United States•
About: Drexel University is a education organization based out in Philadelphia, Pennsylvania, United States. It is known for research contribution in the topics: Population & Poison control. The organization has 26770 authors who have published 51438 publications receiving 1949443 citations. The organization is also known as: Drexel & Drexel Institute.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: An experimental paclitaxel‐induced painful peripheral neuropathy model is described, which may be useful in understanding a significant source of pain in cancer patients, and in finding ways to avoid the neurotoxicity that limits pac litaxel therapy.
Abstract: Paclitaxel, an effective anti-neoplastic agent in the treatment of solid tumors, produces a dose-limiting painful peripheral neuropathy in a clinically significant number of cancer patients. Prior work has demonstrated paclitaxel-induced neurodegeneration and sensory loss in laboratory rodents. We describe here an experimental paclitaxel-induced painful peripheral neuropathy. Adult male rats were given four intraperitoneal injections on alternate days of vehicle or 0.5, 1.0, or 2.0 mg/kg of paclitaxel (Taxol). Behavioral tests for pain using mechanical and thermal stimuli applied to the tail and hind paws, and tests for motor performance, were taken before, during and after dosing for 22-35 days. All three doses of paclitaxel caused heat-hyperalgesia, mechano-allodynia, mechano-hyperalgesia, and cold-allodynia, but had no effect on motor performance. Neuropathic pain began within days and lasted for several weeks. We did not detect any dose-response relationship. Tests at the distal, mid, and proximal tail failed to show evidence of a length-dependent neuropathy. Vehicle control injections had no effect on any measure. No significant systemic toxicities were noted in the paclitaxel-treated animals. Light-microscopic inspection of the sciatic nerve (mid-thigh level), L4-L5 dorsal root ganglia, and dorsal and ventral roots, and the gray and white matter of the L4-L5 spinal cord, showed no structural abnormalities. Electron microscopic examination of the sciatic nerve (mid-thigh level) and the L4-L5 dorsal root ganglia and dorsal horns demonstrated no degeneration of myelinated and unmyelinated axons in the sciatic nerve and roots, but revealed endoneurial edema. This model may be useful in understanding a significant source of pain in cancer patients, and in finding ways to avoid the neurotoxicity that limits paclitaxel therapy.
447 citations
••
TL;DR: Increased central nervous system mediated adrenergic activity and cardiovascular response in labile hypertension and also in some normotensive subjects with a genetic risk for hypertension are demonstrated.
Abstract: The hemodynamic response to mental stress (mental arithmetic) was studied in adolscents with varying risk factors for essential hypertension (EH), One group (genetic) consisted of normotensive well adolescents who had at least one parentnt with EH. Another group (labile) consisted of adolescents with labile hypertension each of whom also had at least one pare with EH. The control population consisted of normotensive adolescents with a negative family history of EH. Subjects with labile hypertension demonstrated a sustained increase in systolic and diastolic pressure and heart rate during stress. This response was significantly different than the control population (P less than THE CONTROL POPULATION (P LESS THAN 0.001). The stress response of the normotensive genetic population was qualitatively similar to the group with labile hypertension and significantly different than the controls in diastolic pressure and heart rate (p less than 0.001, less than 0.02). Post-stress plasma catecholamines were higher in the labile hypertensive and genetic groups than in the control group. These findings demonstrate increased central nervous system mediated adrenergic activity and cardiovascular response in labile hypertension and also in some normotensive subjects with a genetic risk for hypertension.
447 citations
••
TL;DR: Recording neuronal activity from neurosurgical patients performing a virtual-navigation task, it is identified cells exhibiting grid-like spiking patterns in the human brain, suggesting that humans and simpler animals rely on homologous spatial-coding schemes.
Abstract: Grid cells in the entorhinal cortex appear to represent spatial location via a triangular coordinate system. Such cells, which have been identified in rats, bats and monkeys, are believed to support a wide range of spatial behaviors. Recording neuronal activity from neurosurgical patients performing a virtual-navigation task, we identified cells exhibiting grid-like spiking patterns in the human brain, suggesting that humans and simpler animals rely on homologous spatial-coding schemes.
447 citations
••
TL;DR: The objective of this article is to illustrate the power of spatial models and analytical techniques in the design of wireless networks, and to provide an entry-level tutorial.
Abstract: The performance of wireless networks depends critically on their spatial configuration, because received signal power and interference depend critically on the distances between numerous transmitters and receivers. This is particularly true in emerging network paradigms that may include femtocells, hotspots, relays, white space harvesters, and meshing approaches, which are often overlaid with traditional cellular networks. These heterogeneous approaches to providing high-capacity network access are characterized by randomly located nodes, irregularly deployed infrastructure, and uncertain spatial configurations due to factors like mobility and unplanned user-installed access points. This major shift is just beginning, and it requires new design approaches that are robust to spatial randomness, just as wireless links have long been designed to be robust to fading. The objective of this article is to illustrate the power of spatial models and analytical techniques in the design of wireless networks, and to provide an entry-level tutorial.
446 citations
••
State University of New York System1, Detroit Medical Center2, Universidade Federal do Rio Grande do Sul3, Rappaport Faculty of Medicine4, Rambam Health Care Campus5, National and Kapodistrian University of Athens6, University of North Carolina at Chapel Hill7, University of Genoa8, Drexel University9, Erasmus University Rotterdam10, University of Houston11, Mahidol University12, Northwestern University13, Monash University, Clayton campus14, Monash University15, University of Michigan16
TL;DR: In this paper, the authors report consensus therapeutic guidelines for agent selection and dosing of colistin and polymyxin antibiotics for optimal use in adult patients, as endorsed by the American College of Clinical Pharmacy (ACCP), Infectious Diseases Society of America (IDSA), International Society of Anti-Infective Pharmacology (ISAP), Society for Critical Care Medicine (SCCM), and Society of Infectious diseases Pharmacists (SIDP).
Abstract: The polymyxin antibiotics colistin (polymyxin E) and polymyxin B became available in the 1950s and thus did not undergo contemporary drug development procedures. Their clinical use has recently resurged, assuming an important role as salvage therapy for otherwise untreatable gram-negative infections. Since their reintroduction into the clinic, significant confusion remains due to the existence of several different conventions used to describe doses of the polymyxins, differences in their formulations, outdated product information, and uncertainties about susceptibility testing that has led to lack of clarity on how to optimally utilize and dose colistin and polymyxin B. We report consensus therapeutic guidelines for agent selection and dosing of the polymyxin antibiotics for optimal use in adult patients, as endorsed by the American College of Clinical Pharmacy (ACCP), Infectious Diseases Society of America (IDSA), International Society of Anti-Infective Pharmacology (ISAP), Society for Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). The European Society for Clinical Microbiology and Infectious Diseases (ESCMID) endorses this document as a consensus statement. The overall conclusions in the document are endorsed by the European Committee on Antimicrobial Susceptibility Testing (EUCAST). We established a diverse international expert panel to make therapeutic recommendations regarding the pharmacokinetic and pharmacodynamic properties of the drugs and pharmacokinetic targets, polymyxin agent selection, dosing, dosage adjustment and monitoring of colistin and polymyxin B, use of polymyxin-based combination therapy, intrathecal therapy, inhalation therapy, toxicity, and prevention of renal failure. The treatment guidelines provide the first ever consensus recommendations for colistin and polymyxin B therapy that are intended to guide optimal clinical use.
446 citations
Authors
Showing all 26976 results
Name | H-index | Papers | Citations |
---|---|---|---|
John Q. Trojanowski | 226 | 1467 | 213948 |
Peter Libby | 211 | 932 | 182724 |
Virginia M.-Y. Lee | 194 | 993 | 148820 |
Yury Gogotsi | 171 | 956 | 144520 |
Dennis R. Burton | 164 | 683 | 90959 |
M.-Marsel Mesulam | 150 | 558 | 90772 |
Edward G. Lakatta | 146 | 858 | 88637 |
Gordon T. Richards | 144 | 613 | 110666 |
David Price | 138 | 1687 | 93535 |
Joseph Sodroski | 138 | 542 | 77070 |
Hannu Kurki-Suonio | 138 | 433 | 99607 |
Jun Lu | 135 | 1526 | 99767 |
Stephen F. Badylak | 133 | 530 | 57083 |
Michael E. Thase | 131 | 923 | 75995 |
Edna B. Foa | 129 | 588 | 73034 |